G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/68 (2006.01) A61K 31/12 (2006.01)
Patent
CA 2489294
The present invention relates to a method for identifying and/or validating candidate substances for the treatment of Friedreich Ataxia (FRDA). Furthermore, the present invention relates to the use of selenium, Ebselen and Glutathione peroxidase (GPX) mimetics for the preparation of a medicament for the treatment of FRDA. Another aspect of the present invention relates to the use of cells with reduced frataxin expression for identifying and/or validating candidate substances for the treatment of Friedreich Ataxia.
L'invention concerne une m~thode d'identification et/ou de validation de substances candidates pour le traitement de la maladie de Friedreich. Par ailleurs, l'invention porte sur l'utilisation de substances mim~tiques de la gluthation p~roxydase (GPX), du s~l~nium et de l'Ebs~lne pour la pr~paration d'un m~dicament pour le traitement de ladite maladie. Selon un autre aspect de l'invention, l'utilisation de cellules ~ expression r~duite de frataxine pour l'identification et/ou la validation de substances candidates pour le traitement de la maladie de Friedreich est d~crite.
Jauslin Matthias
Meier Thomas
Schoumacher Fabrice
Borden Ladner Gervais Llp
Santhera Pharmaceuticals (schweiz) Gmbh
LandOfFree
A screening method and compounds for treating friedreich ataxia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A screening method and compounds for treating friedreich ataxia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A screening method and compounds for treating friedreich ataxia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1548924